ISB News

Tackling Lyme Disease with Immunity

It’s Lyme disease season in many areas of the United States, including the Northeast, the Midwest, and some places on the West Coast. About 30,000 Lyme disease cases are reported to the Centers for Disease Control and Prevention each year, but that number is likely far lower than the actual number of people diagnosed each year. Some estimates suggest that nearly 500,000 people get Lyme disease annually in the U.S. alone.

ISB Associate Professor Dr. Naeha Subramanian participated in ISB’s latest Research Roundtable event. Lyme disease is just one of the research areas studied by the Subramanian Lab. Subramanian delivered a presentation called “Tackling Lyme Disease with Immunity,” which you can watch here or by clicking play on the video at the top of this story.

Research Roundtables

ISB is hosting a series of Research Roundtable conversations throughout 2021 that will feature our leading scientists discussing their latest research. These events are designed for the novice scientist and the expert alike, and are open to anyone interested in the topics. Featured scientists will also answer your questions.

Next up in our series is Dr. Andrew Magis, who on September 21 will discuss identifying markers for cancer years before diagnosis (sign up here).

Past Research Roundtable events have featured ISB Co-founder Dr. Lee Hood, microbiome specialist and ISB Assistant Professor Dr. Sean Gibbons, and Alzheimer’s disease expert and ISB Senior Research Scientist Dr. Jared Roach. You can read about their talks and watch their presentations here, here and here, respectively.

Recent Articles

  • Wei Lab

    New Technology Reveals Single Cancer Cells Have Different Appetites for Fatty Acids

    A recently developed method by the Wei Lab at Institute for Systems Biology (ISB) and University of California, Riverside provides new insights into cancer biology by allowing researchers to show how fatty acids are absorbed by single cells. This work was published in the Journal of the American Chemical Society.

  • Glioblastoma tumor slice and corresponding density map

    Looking at Tumors Through a New Lens

    To improve the efficacy of neoadjuvant immune checkpoint blockade against glioblastoma, researchers are looking for vulnerabilities in surgically removed tissues – a difficulty due to the vast differences within the tumor and between patients. To address this, ISB researchers and their collaborators developed a new way to study tumors.

  • Fireside Chat with NIH Director Francis Collins and ISB Co-founder Dr. Lee Hood

    ISB Co-founder Dr. Lee Hood hosted a fireside chat with NIH Director Dr. Francis Collins. The renowned scientists talked about their early careers and long friendship, the challenge of COVID-19, the preceding scientific work that led to the fast development of COVID vaccines, and much more.